Related Experiment Videos
The secondarily generalized tonic-clonic seizure: a videotape analysis
W H Theodore1, R J Porter, P Albert
1Clinical Epilepsy Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892.
Neurology
|August 1, 1994
Summary
Generalized tonic-clonic seizures (GTCSs) show varied phases and durations, often preceded by other seizure types. Prompt intervention with antiepileptic drugs is crucial for prolonged seizures.
Area of Science:
- Clinical Neurology
- Epileptology
- Neurophysiology
Background:
- Generalized tonic-clonic seizures (GTCSs) are a significant manifestation of epilepsy.
- Understanding the detailed phenomenology and progression of GTCSs is crucial for effective management.
- Antecedent seizure types can precede the occurrence of GTCSs, indicating complex seizure dynamics.
Purpose of the Study:
- To analyze the detailed phases and clinical variability of generalized tonic-clonic seizures (GTCSs).
- To investigate the relationship between antecedent seizures and GTCS presentation.
- To provide evidence-based recommendations for the management of prolonged GTCSs.
Main Methods:
- Retrospective analysis of 120 generalized tonic-clonic seizures (GTCSs) from 47 patients.
- Utilized video-electroencephalography (EEG) telemetry for detailed seizure recording and analysis.
- Categorized GTCSs into distinct phases: onset of generalization, pretonic clonic, tonic, tremulousness, and clonic.
Main Results:
- The mean duration of GTCSs was 62 seconds, with significant heterogeneity in phase expression.
- Only 27% of GTCSs exhibited all five defined phases, highlighting variability in seizure progression.
- A trend towards longer GTCS duration was observed with reduced antiepileptic drug dosages, though not statistically significant.
Conclusions:
- Generalized tonic-clonic seizures (GTCSs) display marked heterogeneity in their clinical presentation and phase progression.
- The diverse phenomenology suggests complex cortical and subcortical seizure spread pathways.
- Intravenous antiepileptic drug treatment is recommended for GTCSs exceeding 2 minutes in duration.